combination therapy

You have access
Clinical Trial Protocol for LuCAB: A Phase I–II Trial Evaluating Cabazitaxel in Combination with [¹⁷⁷Lu]Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer
Louise Kostos, James P. Buteau, Grace Kong, Ben Tran, Mohammad B. Haskali, Michael Fahey, Megan Crumbaker, Louise Emmett, Michael S. Hofman and Arun A. Azad

Journal of Nuclear Medicine April 1, 2025, 66 (4) 572-578; DOI: https://doi.org/10.2967/jnumed.124.269252
You have access
PET Imaging of PD-L1 Occupancy for Preclinical Assessment of the Efficacy of Combined Anti–PD-L1 Immunotherapy and Targeted Therapy
Céline Chevaleyre, Léa Zimmermann, Simon Specklin, Dimitri Kereselidze, Alizée Bouleau, Steven Dubois, Hélène Quelquejay, Bernard Maillère, Nicolas Tournier, Hervé Nozach and Charles Truillet

Journal of Nuclear Medicine April 1, 2025, 66 (4) 559-564; DOI: https://doi.org/10.2967/jnumed.124.268586
Open Access
Combination Strategies to Improve Targeted Radionuclide Therapy
Tiffany G. Chan, Edward O’Neill, Christine Habjan and Bart Cornelissen

Journal of Nuclear Medicine November 1, 2020, 61 (11) 1544-1552; DOI: https://doi.org/10.2967/jnumed.120.248062
You have access
Significant Therapeutic Efficacy with Combined Radioimmunotherapy and Cetuximab in Preclinical Models of Colorectal Cancer
Vessela Vassileva, Vineeth Rajkumar, Mario Mazzantini, Mathew Robson, Adam Badar, Surinder Sharma, Erik Årstad, Daniel Hochhauser, Mark F. Lythgoe, Geoffrey M. Boxer and Rosmund Barbara Pedley

Journal of Nuclear Medicine August 1, 2015, 56 (8) 1239-1245; DOI: https://doi.org/10.2967/jnumed.115.157362
You have access
Treatment of Triple-Negative Breast Cancer Using Anti-EGFR–Directed Radioimmunotherapy Combined with Radiosensitizing Chemotherapy and PARP Inhibitor
Fares Al-Ejeh, Wei Shi, Mariska Miranda, Peter T. Simpson, Ana Cristina Vargas, Sarah Song, Adrian P. Wiegmans, Alex Swarbrick, Alana L. Welm, Michael P. Brown, Georgia Chenevix-Trench, Sunil R. Lakhani and Kum Kum Khanna

Journal of Nuclear Medicine June 1, 2013, 54 (6) 913-921; DOI: https://doi.org/10.2967/jnumed.112.111534
You have access
Targeted Radiotherapy of Prostate Cancer with a Gastrin-Releasing Peptide Receptor Antagonist Is Effective as Monotherapy and in Combination with Rapamycin
Rebecca A. Dumont, MariaLuisa Tamma, Friederike Braun, Sandra Borkowski, Jean Claude Reubi, Helmut Maecke, Wolfgang A. Weber and Rosalba Mansi

Journal of Nuclear Medicine May 1, 2013, 54 (5) 762-769; DOI: https://doi.org/10.2967/jnumed.112.112169

Main menu

User menu

Search

combination therapy